A man from Quebec, aged 64, has made history in North America by being the first recipient of a regenerated liver, utilizing innovative technology that has the potential to increase the availability of transplantable livers significantly within its initial year. Gérard Landry, a resident of Nouvelle in Quebec’s Gaspé Peninsula, battled liver issues for around 15 years, leading to cirrhosis and liver cancer.
Before undergoing liver transplant surgery, Landry received surprising news from his doctor that his new liver had been regenerated using a novel machine, a first at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM). Describing it as a “Christmas gift,” Landry expressed his gratitude for the new technology developed by his doctor over several years.
The revolutionary technology, Liver Assist, enables medical professionals to treat and evaluate a donated liver externally before transplantation. In Landry’s case, this breakthrough meant he could receive a liver that would have otherwise been deemed too risky for transplantation.
Dr. David Hénault, a liver transplant specialist at CHUM, spearheaded the project and conducted Landry’s surgery, with the team having prepared for the technology’s implementation for approximately three years. Liver Assist functions by connecting a donated liver to a machine that circulates an oxygen-rich fluid through the organ, potentially reversing oxygen deprivation-induced damage while the liver is outside the body.
After this initial treatment, doctors can switch to a blood-based solution to assess the liver’s functionality in conditions simulating those of the human body. Hénault emphasized that the technology proves promising by demonstrating successful outcomes early on, indicating positive signs for patients like Landry.
The implementation of Liver Assist at CHUM has the potential to significantly increase the number of available livers for transplantation, with an estimated 20 to 24 additional livers being deemed suitable for transplantation annually in the initial phase of its use. Hénault envisions a future where the technology will benefit numerous patients awaiting life-saving liver transplants.
Beyond increasing the availability of livers, studies have shown that the new technology can lead to reduced complications, reoperations, and hospital stays for eligible patients. Landry’s post-transplant recovery progress has been notably swift, with Hénault attributing this success partly to the assistance provided by the machine during the transplantation process.
Landry, currently in recovery in Montreal and undergoing regular blood tests, looks forward to returning to his hometown of Gaspésie as he continues his recuperation. Expressing eagerness to reunite with his family, grandson, friends, and horses, Landry hopes his experience will inspire discussions about organ donation, emphasizing the importance of having donated organs available for those in need.